Emerging therapeutic strategies for Epstein-Barr virus+ post-transplant lymphoproliferative disorder.

Abstract

De novo malignancies represent an increasing concern in the transplant population, particularly as long-term graft and patient survival improves. EBV-associated B-cell lymphoma in the setting of PTLD is the leading malignancy in children following solid organ transplantation. Therapeutic strategies can be categorized as pharmacologic, biologic, and cell… (More)
DOI: 10.1111/j.1399-3046.2012.01656.x

Topics

2 Figures and Tables

Cite this paper

@article{Hatton2012EmergingTS, title={Emerging therapeutic strategies for Epstein-Barr virus+ post-transplant lymphoproliferative disorder.}, author={Olivia L Hatton and Olivia M. Martinez and Carlos O. Esquivel}, journal={Pediatric transplantation}, year={2012}, volume={16 3}, pages={220-9} }